ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

36 links0 made here, not in the record36 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07352566Utilization of aMicrodevice for Psoriasisand Atopic DermatitisUniversity of California, San Phase 4 · not yet recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSPsoriasisThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDermatitis, AtopicThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSTriamcinoloneIntervention entry›Nov 18 · Rule based · TestedTestedFluorouracilEntry “5-Fluorouracil”, read by our n…›Nov 18 · Rule based · TestedTestedCalcipotrieneIntervention entry›Nov 18 · Rule based · TestedTestedTapinarofIntervention entry›Nov 18 · Rule based · TestedTestedCrisaboroleIntervention entry›Nov 18 · Rule based · TestedTestedTacrolimusIntervention entry›Nov 18 · Rule based · TestedTestedAdalimumabIntervention entry›Nov 18 · Rule based · TestedTestedEtanerceptIntervention entry›Nov 18 · Rule based · TestedTestedCertolizumab PegolEntry “Certolizumab”, read by our nam…›Nov 18 · Rule based · TestedTestedInfliximabIntervention entry›Nov 18 · Rule based · TestedTestedSecukinumabIntervention entry›Nov 18 · Rule based · TestedTestedIxekizumabIntervention entry›Nov 18 · Rule based · TestedTestedApremilastIntervention entry›Nov 18 · Rule based · TestedTestedRisankizumabIntervention entry›Nov 18 · Rule based · TestedTestedUstekinumabIntervention entry›Nov 18 · Rule based · TestedTestedHydroxychloroquineIntervention entry›Nov 18 · Rule based · TestedTestedMethotrexateIntervention entry›Nov 18 · Rule based · TestedTestedMycophenolic AcidEntry “Mycophenolate”, read by our na…›Nov 18 · Rule based · TestedTestedAzathioprineIntervention entry›Nov 18 · Rule based · TestedTestedChloroquineIntervention entry›Nov 18 · Rule based · TestedTestedCyclosporineIntervention entry›Nov 18 · Rule based · TestedTestedTofacitinibIntervention entry›Nov 18 · Rule based · TestedTestedDeucravacitinibIntervention entry›Nov 18 · Rule based · TestedTestedDupilumabIntervention entry›Nov 4 · Claude Opus 5.5 · ProcedureNov 18 · Rule based · TestedTestedTralokinumabIntervention entry›Nov 18 · Rule based · TestedTestedGuselkumabIntervention entry›Nov 18 · Rule based · TestedTestedTildrakizumabIntervention entry›Nov 18 · Rule based · TestedTestedAbrocitinibIntervention entry›Nov 18 · Rule based · TestedTestedUpadacitinibIntervention entry›Nov 18 · Rule based · TestedTestedLebrikizumabIntervention entry›Nov 18 · Rule based · TestedTestedNemolizumabIntervention entry›Nov 18 · Rule based · TestedTestedRuxolitinibIntervention entry›Nov 18 · Rule based · TestedTestedBimekizumabIntervention entry›Nov 18 · Rule based · TestedTestedRoflumilastIntervention entry›Nov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Dupilumab

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Dupilumab”the record gives no role
→judged→changed
How the 2 judgments split50%of judgments with a known value say Tested
Tested · 1
Procedure · 1

All judgments on this study

WhenLinkJudgeDecisionState
Nov 4DupilumabClaude Opus 5.5ProcedureCurrent
Nov 18TriamcinoloneRule based · role ruleTestedCurrent
Nov 18FluorouracilRule based · role ruleTestedCurrent
Nov 18CalcipotrieneRule based · role ruleTestedCurrent
Nov 18TapinarofRule based · role ruleTestedCurrent
Nov 18CrisaboroleRule based · role ruleTestedCurrent
Nov 18TacrolimusRule based · role ruleTestedCurrent
Nov 18AdalimumabRule based · role ruleTestedCurrent
Nov 18EtanerceptRule based · role ruleTestedCurrent
Nov 18Certolizumab PegolRule based · role ruleTestedCurrent
Nov 18InfliximabRule based · role ruleTestedCurrent
Nov 18SecukinumabRule based · role ruleTestedCurrent
Nov 18IxekizumabRule based · role ruleTestedCurrent
Nov 18ApremilastRule based · role ruleTestedCurrent
Nov 18RisankizumabRule based · role ruleTestedCurrent
Nov 18UstekinumabRule based · role ruleTestedCurrent
Nov 18HydroxychloroquineRule based · role ruleTestedCurrent
Nov 18MethotrexateRule based · role ruleTestedCurrent
Nov 18Mycophenolic AcidRule based · role ruleTestedCurrent
Nov 18AzathioprineRule based · role ruleTestedCurrent
Nov 18ChloroquineRule based · role ruleTestedCurrent
Nov 18CyclosporineRule based · role ruleTestedCurrent
Nov 18TofacitinibRule based · role ruleTestedCurrent
Nov 18DeucravacitinibRule based · role ruleTestedCurrent
Nov 18DupilumabRule based · role ruleTestedCurrent
Nov 18TralokinumabRule based · role ruleTestedCurrent
Nov 18GuselkumabRule based · role ruleTestedCurrent
Nov 18TildrakizumabRule based · role ruleTestedCurrent
Nov 18AbrocitinibRule based · role ruleTestedCurrent
Nov 18UpadacitinibRule based · role ruleTestedCurrent
Nov 18LebrikizumabRule based · role ruleTestedCurrent
Nov 18NemolizumabRule based · role ruleTestedCurrent
Nov 18RuxolitinibRule based · role ruleTestedCurrent
Nov 18BimekizumabRule based · role ruleTestedCurrent
Nov 18RoflumilastRule based · role ruleTestedCurrent
As of nowPsoriasisRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.